In 2026, the clinical standard for managing testosterone replacement therapy (TRT) emphasises that the initial year is the most critical period for monitoring. Because the body response to hormonal therapy is highly individualised, regular checks are essential to ensure the dose is effective, safe, and balanced. Once a patient reaches a stable state where symptoms are resolved and health markers are optimal, the frequency of testing typically decreases.
What We Will Cover in This Article
- The 2026 monitoring timeline for the first twelve months
- Key blood markers including Testosterone, Haematocrit, and PSA
- Why monitoring frequency changes once a patient is stable
- The importance of timing your blood draw based on your medication type
- Red flags that require immediate unscheduled medical testing
- The role of physical examinations in long term monitoring
The First Year: The Titration Phase
When you first start treatment, your physician needs to see how your body processes the external hormone. In 2026, the British Society for Sexual Medicine and European guidelines recommend a standardised follow-up schedule.
- 3 Month Check: This is the most important initial follow-up. It is used to assess your early symptomatic response and check for any immediate side effects. Your doctor will likely adjust your dose at this stage.
- 6 Month Check: By this point, most physical changes, such as muscle mass shifts and metabolic improvements, are beginning to stabilise.
- 12 Month Check: This marks the end of the initial titration phase. If your blood markers are healthy and your symptoms are controlled, you are considered stable.
What Markers are Monitored?
A follow-up is not just about checking your testosterone level. In 2026, we monitor a full profile to ensure total systemic safety.
| Marker | Why We Monitor It |
| Total and Free Testosterone | To ensure you are within the healthy physiological range. |
| Haematocrit (FBC) | To ensure your blood is not becoming too thick or viscous. |
| PSA (Prostate Specific Antigen) | To monitor prostate health, especially in men over 45. |
| Oestradiol | To ensure testosterone is not converting excessively into oestrogen. |
| Lipid Profile | To monitor the impact of therapy on your cholesterol levels. |
Timing the Blood Draw
In 2026, the timing of your follow-up blood test is strictly dictated by the type of treatment you are using. Testing at the wrong time can lead to incorrect dose adjustments.
- Topical Gels: Blood should typically be drawn in the morning, 2 to 4 hours after application, to capture the peak absorption level.
- Short Acting Injections: Tests are usually performed midway between injections or at the trough, which is just before the next dose, to see your lowest point.
- Long Acting Injections: Monitoring is performed at the trough, specifically on the day of your next injection before it is administered.
Long Term Maintenance: Annual Monitoring
Once you have completed your first year and your dose is stable, the monitoring frequency usually drops to once every 12 months.
However, annual monitoring is mandatory. In 2026, many clinicians will not issue further prescriptions if the annual blood work and physical check, including a prostate examination if indicated, are not completed. This long term oversight ensures that the therapy continues to provide benefits without introducing silent risks like elevated blood pressure or heart strain.
To Summarise
Effective testosterone management requires a commitment to regular monitoring. You should expect frequent blood tests at 3, 6, and 12 months during your first year, followed by an annual check up thereafter. These tests are the only way to prove that your treatment is optimised for both performance and safety. In 2026, the goal is not just to raise your levels, but to keep every health marker within a range that supports long term longevity.
If you have recently started treatment or have not had a check up in over a year, your next step is to book a comprehensive male hormone monitoring panel.
Do I need a prostate exam at every follow-up?
Not necessarily. In 2026, a Digital Rectal Examination is usually performed at baseline and again at 6 or 12 months. After that, it is typically done annually alongside your PSA blood test.
What happens if my haematocrit is too high?
If your haematocrit exceeds 54 percent, your doctor may recommend donating blood, reducing your testosterone dose, or switching from injections to a daily gel.
Can I skip a follow-up if I feel great?
No. Many side effects, such as a rise in red blood cells or PSA, do not have immediate symptoms. Monitoring is designed to catch these before they become health issues.
What if I change my dose on my own?
You should never adjust your dose without a blood test and clinical consultation. Changing the dose alters your hormonal balance and requires a new 3 month monitoring cycle.
Do I need to fast for my follow-up tests?
Yes. While testosterone itself does not require fasting, the accompanying lipid and glucose checks usually do. Always check with your clinic beforehand.
Is it normal for PSA to rise slightly on TRT?
A modest rise is common as the prostate responds to restored testosterone levels. However, a rapid or significant increase will trigger a referral to a urologist.
Authority Snapshot
This article was written by the MyPatientAdvice clinical team and reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and extensive experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov holds postgraduate certifications in ACLS and BLS and has worked in both hospital wards and intensive care units. He specialises in medical education and the creation of evidence based health content and teaching clinical skills to junior doctors.
